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ABSTRACT
Motivation: Post-translational modifications are vital to the
function of proteins, but are hard to study, especially since several
modified isoforms of a protein may be present simultaneously.
Mass spectrometers are a great tool for investigating modified
proteins, but the data they provide is often incomplete,
ambiguous and difficult to interpret. Combining data from multiple
experimental techniques—especially bottom-up and top-down
mass spectrometry—provides complementary information. When
integrated with background knowledge this allows a human
expert to interpret what modifications are present and where on a
protein they are located. However, the process is arduous and for
high-throughput applications needs to be automated.
Results: This article explores a data integration methodology based
on Markov chain Monte Carlo and simulated annealing. Our software,
the Protein Inference Engine (the PIE) applies these algorithms using
a modular approach, allowing multiple types of data to be considered
simultaneously and for new data types to be added as needed. Even
for complicated data representing multiple modifications and several
isoforms, the PIE generates accurate modification predictions,
including location. When applied to experimental data collected on
the L7/L12 ribosomal protein the PIE was able to make predictions
consistent with manual interpretation for several different L7/L12
isoforms using a combination of bottom-up data with experimentally
identified intact masses.
Availability: Software, demo projects and source can be
downloaded from http://pie.giddingslab.org/
Contact: morgan@giddingslab.org.
Supplementary information: Supplementary data are available at
Bioinformatics online
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1 INTRODUCTION
A cell needs to modify proteins with post-translational adducts for
the same reason that an automobile needs gears: without them
the operational range is severely limited. If cells relied on fixed
proteins, biological reaction times would be on the order of minutes
and only a limited set of functional groups would be available to
∗To whom correspondence should be addressed.
build an active protein. Cells use ≥300 known post-translational
modifications (PTMs) (Creasy and Cottrell, 2004) to allow dynamic
‘functional shifting’, providing for rapid and flexible responses to
changing local conditions. These PTMs affect protein functions in
many ways, including inducing conformation changes (Huse and
Kuriyan, 2002), modifying protein–protein interactions (Seet et al.,
2006), and affecting lifespan (Giglione et al., 2003; Hochstrasser,
1996). When PTM regulation breaks down, it is much like a broken
transmission in a car—proteins become non-functional (Banerjee
and Gerondakis, 2007; Giannopoulos, 2009; Minamoto et al., 2001;
Shi, 2007). Teasing apart where PTMs occur, when they are used,
and how they are modulated is of great interest in biological and
biomedical research.
Studying PTMs requires examining proteins, but without the
equivalent of polymerase chain reaction (PCR) amplification
techniques, proteomics methods are significantly more difficult and
indirect than genomic methods. Mass spectrometry (MS) is the
star player in the proteomics field, and with the advent of new
instrumentation such as orbitrap mass analyzers (Perry et al., 2008)
combined with the continued maturation of established techniques
such as electrospray ionization (Maxwell and Chen, 2008), it is an
excellent tool for the investigation of PTMs. Current MS methods
measure protein or peptide mass with such accuracy that it is possible
to differentiate between two distinct modification states (isoforms)
of a protein based only on a mass shift. For example, methylation
adds +14.0 Da to the total mass of the protein. If it is possible to
measure the intact mass of that protein within ∼1 Da or less, then
this methylation can be readily detected.
However, in practice, PTM analysis is not simple. Even putting
aside sample preparations issues (Fang et al., 2010), analytical
difficulties remain, including: (i) achieving sufficient accuracy to
determine PTMs for large proteins; (ii) working with obstinate,
insoluble proteins (Mirzaei and Regnier, 2006); (iii) decoding
isobaric masses, when multiple combinations of PTMs give the same
mass shift (e.g. both one acetylation and three methylations cause
a 42.0 Da mass shift); and (iv) determining precise positioning of
PTMs. Several approaches have been devised that address these
challenges, including bottom-up, top-down and combined methods.
We briefly describe these here; more detailed reviews are available
(e.g. Bogdanov and Smith, 2005; Domon and Aebersold, 2006;
Kelleher 2004; Yates et al., 2009).
Bottom-up MS uses a divide-and-conquer strategy that reduces
proteins to constituent, short peptides that are more readily
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analyzed. The procedure begins by digesting a protein into
peptides, generally with an enzyme such as trypsin that cleaves at
predictable sites. These peptides are then separated based on distinct
chromatographic and/or chemical properties and analyzed by MS to
infer PTMs.
Bottom-up methodologies simplify the analysis of PTMs by
producing smaller, more accurately measurable peptides and by
decoupling modifications that fall on different peptides. However,
although reduced in scope, the basic problem of determining
modification locations and resolving isobaric masses remains. To
overcome this, we can apply another round of divide-and-conquer,
breaking a peptide into a set of constituent fragments. Given
enough fragments, the amino acid sequence of the peptide can be
reconstructed. This process, termed tandem MS (MS/MS), can be
used to precisely locate a PTM on a given residue in the peptide,
since it will cause a discernible shift at that site.
Though the combined bottom-up and MS/MS strategy is quite
powerful, the decoupling of PTMs into separate peptides makes
it difficult to resolve which specific combinations of PTMs were
present on the original protein isoform. For example, if a protein
has two phosphorylation sites, each on a separate peptide, it is not
possible using a bottom-up strategy to tell the difference between a
sample containing a mix of an unmodified and a doubly modified
isoform variant, versus a sample containing a mix of two singly
phosphorylated isoforms (each phosphorylated at one of the two
sites). The digestion step used by the bottom-up approach converts
either protein mix into identical peptide sets, each containing a
modified and an unmodified version of each phosphorylation site.
Another challenge with the bottom-up MS/MS approach is the
high frequency of missing peptides. Complete peptide coverage
requires that each peptide has appropriate concentration, solubility
and MS ionization. If a peptide is not observed, all information
regarding its PTMs is lost.
Top-down MS starts by determining the intact mass of a protein
and then applies a fragmentation step directly to the protein species
being analyzed. This is also a divide-and-conquer approach, but it
is applied rapidly and dynamically inside the mass spectrometer.
For proteins whose solubility and size allows loading and detection,
top-down MS has great potential as a faster and more complete way
of analyzing PTMs on proteins, but the resulting spectra can be
very complex, and the technology is still being developed (Kellie
et al., 2010).
Combined top-down and bottom-up (TDBU) MS uses both an
intact protein mass and the more readily obtainable bottom-up
MS/MS data. Together these data provide more complete and
comprehensive information than either alone, and can be used for
more comprehensive PTM inference.
Unfortunately, data integration for TDBU is hard. Experience
in our laboratory trying to put together intact mass, peptide and
MS/MS data for a study of ribosome modification (Ramkisoon,K.
and Giddings,M.C., unpublished data) revealed the difficulty of
manual integration. Due to incomplete bottom-up information and
the multiple isobaric PTM configurations, there are many possible
interpretations for any dataset. Nevertheless, with substantial human
effort it is often possible to produce a clear good answer. Generally,
these answers are not absolute, but an expert can generally provide
a concordant argument for their choices. This kind of reasoning is
difficult to turn into an effective and practical computer algorithm.
Yet, the flood of new MS data does not allow for human experts to
examine every output, necessitating computational tools that make
the process significantly more efficient.
The advent of combined approaches such as TDBU is very
recent, so not many supporting tools exist to aid in this integration
problem. A number of programs exist that can determine PTMs from
either bottom-up or top-down data alone. To interpret bottom-up
data, most use an alignment algorithm to compare experimentally
acquired peptide MS/MS spectra against a database of known
spectra. Interpreting the difference allows identification of PTMs.
Some examples are cross-correlation (Yates et al., 1995), Mascot
(Perkins et al., 1999), TANDEM (Craig and Beavis, 2004) or
InsPecT (Tanner et al., 2005). A few algorithms or programs can
do de novo interpretation of the MS/MS spectra, e.g. Spectral
Dictionary (Kim et al., 2009) or an Integer programming-based
algorithm, PILOT_PTM (Baliban et al., 2010). Fewer programs
exist that interpret top-down (intact mass) data in isolation, as each
has to handle the large number of isobaric masses produced from
various combinations of PTMs. Proclame (Holmes and Giddings,
2004) is one, using fuzzy logic to constrain the search space.
Additionally, there are a growing number of programs that make
specific, focused PTM predictions based on the sequence data,
without considering the MS data [e.g. SignalP (Bendtsen et al., 2004)
and NetPhos (Blom et al., 1999)]. Unfortunately these programs
work in almost total isolation, unaware of and unable to include
results from each other, and they tend to be limited in scope or in
the type of modifications they can consider.
Since the data integration problem is so great, recent effort has
focused on solving this problem. While various scripts have been
created to search constrained subsets of modification possibilities,
few of those are yet in the published literature. Two that we are
aware of are PTMSearchPlus (Kertesz et al., 2009), wherein they
perform a bounded search constrained by the statistics of the most
likely numbers of modifications to occur, and a high-throughput data
analysis pipeline from the Kelleher group (Durbin et al., 2010). The
pipeline combines bottom-up data with intact mass data of different
types (isotope information from high resolution FTMS and change
information from lower resolution ion-trap MS) to identify proteins
and their simply modified isoforms. Though these approaches have
moved the ball forward in this domain, the basic challenge of
integrating arbitrary additional data sources in a way that has no
hard bounds regarding the PTM scenarios considered is difficult
to solve. A human expert uses many other data sources (expressed
as prior knowledge) in determining a final solution, and has the
capability to consider novel situations, outside of the bounds of a
constrained search. With Protein Inference Engine (PIE) we have
not created another algorithm to interpret mass spectra, but a way to
combine the results from other programs that do so. The PIE takes a
holistic approach to the data integration problem, treating each piece
of data as a separate ingredient. Using Markov chain Monte Carlo
(McMC) and SA allows integrating data together, not in the sense
of assembling a puzzle from its pieces but in the sense of baking
a pie, where the whole becomes a different entity, different from
and greater than the sum of its parts. We are unaware of any other
application of McMC or SA to integrate proteomics data.
2 METHODS
We set out to determine whether we could effectively solve this challenge
using a directed stochastic search algorithm. Our goal was to develop a
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platform that could potentially accommodate any type of data or information
that might assist in efficiently finding the best answer from this large search
space. We focused on the initial problem of attempting to integrate intact
mass measurements from top-down analysis, peptide data from bottom-up
analysis, prior statistics about the likelihood of any given modification and
prior human knowledge into a program that can rapidly determine and score
the most likely PTM scenario.
Inspiration for a solution to the data integration problem comes from
Plato’s allegory of the cave (Bloom, 1991). As denizens of the cave, we
cannot directly observe the world, but instead can only see the shadows of
the true reality outside projected on a cave walls. In this analogy, a modified
protein and its PTMs are the truth we are trying to uncover, but it is impossible
to directly observe that truth. We can only see shadows—data revealed by
the light of experiment, i.e. MS and related methods. From these shadows we
can make inferences, guessing at the nature of the underlying, unobservable
truth.
We can formalize this as a collection of data, D, for a protein of interest
and a set of all possible guesses, G, about what the underlying ‘truth’ is—the
protein’s PTM configuration. Our goal is then to identify the guess g∈G
most consistent with the data. To evaluate candidates for the best guess, we
can specify a scoring function S(g|D) that assigns to each guess g a score
based on the available data. In this formulation, the best guess is the one
with the highest value and is the truth we seek:
Best guess for ‘truth’= argmaxg[S(g|D)]
To apply this description of PTM inference and build a prediction engine
for PTMs, we needed to define the solution set G, specify the scoring function
S, and provide a method for finding argmaxg for this D.
2.1 Defining the search space G
Unfortunately, the solution set G is rather large. If we allow for only 10
different modification types, a protein of just 100 residues has a googol
(10100) possible modification states, which is much, much larger than the
age of the universe, in picoseconds (around 1030, Bolte and Hogan, 2002).
It is truly impossible to check each possible scenario to find the best one.
However, by arranging the potential guesses of the set G into a space G where
distances between solutions can be defined and nearby answers have similar
scores, we can then use a heuristic method to search only likely places. Our
search space is represented in Figure 1.
Our solution space G is defined so that guesses (PTM isoforms) that are
close together are similar and hence have similar ‘goodness’. This provides
a rough continuity for the scoring function S() with respect to G and creates
a functional landscape over which we can hunt for the best scoring guess.
2.2 Finding argmaxg(S) by Markov chain Monte Carlo
and SA
The ultimate goal is to find the truth T which is the modified protein variant
underlying the data. The closest we can come to this is argmaxg S(g|D),
so our goal is to efficiently seek that without loss of generality. Metropolis
McMC (Metropolis et al., 1953) is a heuristic method for sampling from
the solution space G using a guided random walk. The walk is directed by
a ratio computed for the scoring function S for two neighboring points: g,
where we currently are and p, a neighboring solution selected randomly as a
possible next step. If where we want to step to has a higher score [the ratio
R=S(p|D)/S(g|D) is ≥1], we always take this step to a better scoring guess,
if not then we only sometimes take this step, with probability R.
Repeated, this walk results in generally climbing toward the highest
scoring (best) points in the space, with the ability to occasionally traverse the
valleys to avoid being permanently stuck at a local maxima. After walking
around for a while we can stop and report the point we are on. This McMC
process samples from the landscape as if it were a normalized probability
distribution. If we repeat this process many times, we will sample the highest
scoring point most often.
Fig. 1. Solution space. Every possible modified protein that PIE can propose
as an answer can be visualized as a jagged line from left to right on the
graph shown. The canonical protein sequence of the target being investigated
is aligned along the x-axis, and the set of modifications searched for
makes up the y-axis. The abbreviated protein sequence shown is from the
L7/L12 ribosomal protein. The 11 modifications shown are those used in
all experiments in this article. Only answers that can be constructed with
modifications from this set can be proposed by PIE. Any modifications from
the set can be used, with a linear drop in speed as the number increases.
A different, unique line is drawn for each possible modification scenario,
formed by connecting the points defined by each adduct modification on
the protein. In the example shown, most adducts are ‘none’ (small points),
but there is a N-terminal acetylation (on leftmost S) and an internal K-
methylation. To allow for cleavages, the left and right ends of the line
do not have to be a the first or the last AA of the protein. An N-terminal
methionine truncation is shown by the line starting on the S and not the
initial M (emphasized by a vertical gray block). This provides a simple way
to visualize the multidimensional solution space where points are answers.
Points that are close together in the solution space are here lines that are
mostly overlapping and represent similar answers.
Unfortunately, the near infinite number of low scoring solutions outweighs
the few high scoring ones, so that the best solution is reported infrequently.
To guide the random walk more efficiently to the best answers, we use
simulated annealing (SA; Kirkpatrick et al., 1983). SA modifies the McMC
walk by scaling down R using a coefficient that decreases gradually with
each step, so that near the end of the run it approaches zero. This has the
effect of gradually bounding the McMC walk, preventing it from crossing
ever shallower valleys, until at the end it can only go uphill. McMC and SA
have long been popular in the physical sciences, and have been successfully
used to explore very difficult biological search spaces. Two examples are Mr
Bayes (Huelsenbeck, 2001) and Rosetta Design (Kaufmann, 2010).
If run long enough, SA will always converge to the highest scoring answer,
but we cannot determine in advance how long that will take. To address
this, we run the algorithm repeatedly to sample from the space of solutions,
providing an empirical distribution showing the frequency with which a
given answer is obtained. The true maxima will be found more and more
frequently with longer and longer searches. Specifically, we sample 10 times,
increase the run length and repeat until we observe convergence.
Although the highest scoring answer is our best guess given the data
and scoring models, there may be other guesses that score nearly as
well. By sampling suboptimal answers, we can determine how consistently
the algorithm and data support a single candidate above all others and
reveal difference between situations where the data support several nearly
equivalent solutions versus ones where data support only a single best answer.
To investigate this empirical distribution of possible answers and their scores,
we again profile answers by sampling over 100 runs at a step length estimated
to converge ∼20% of the time.
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Table 1. Data-specific scoring modules
Term Model Data type Model type
S1 Intact mass Experimental 1/x
S2 Peptide mass Experimental 1/x
S3 MS/MS sequence Experimental an
S4 Adduct frequency Prior
∏
i fi
S5 Adduct location Prior
∏
i fi
S6 Adduct count Prior 1/x
S7 N-cleavage Prior an




2.3 Specifying the scoring function S()
In order to specify a flexible scoring function compatible with McMC search,
we require the following properties: it must be defined and non-negative for
all possible guesses, it must model data such that better supported guesses
have higher scores, and the ratio between the scores of any two guesses
should reflect the relative support for those guesses given the data.
We considered that available data D would consist of some varying
combination of up to k different data types including an intact mass
measurement (d1), a set of matched peptide masses (d2), a set of MS/MS
sequence data (d3) and multiple prior data types. Defining a complete joint
probability distribution P(G|D) is not possible, so we make the assumption
that each data type is independent. As with naive Bayesian classifiers, the
error this introduces should at least partially cancel through the use of
multiple data types (Zhang, 2004). This allows us to express P(G|D) as
the product of the individual probabilities for each prior data type
P1(G|d1) ·P2(G|d2) ·····Pk
During its search, McMC only evaluates answers by the ratios of their
probabilities, not their absolute probability of occurrence. This allows us
to take a substantial shortcut by representing prior data types through a
non-normalized scoring function. Expressed for a single guess g∈G this is:
S(g|D)=S1(g|d1) ·S2(g|d2)·····Sk
The requirements for each factor in this scoring function are the same
as those we first outlined, but applied to each type separately. We can add
arbitrary new data types in the future by developing and adding new scoring
terms that meet these requirements. The data types and associated scoring
terms used in this article are summarized in Table 1. Three type of data models
are used for scoring. The 1/(x) models have a maximum score when the
guess matches numerical data exactly, decreasing as the difference increases.
For example, the experimental intact mass is data, and its difference from the
theoretically calculated intact mass for a guess is a measure of the quality
of that guess with respect to the intact mass data. The an models have a
maximum score when there are a minimum number of mismatches (n=
0), decreasing as the number of mismatches increases. a is a constant <1.
For example, the MS/MS model counts the number of amino acids and
modifications that do not match provided MS/MS sequence information,
and is a measure of the quality of the guess with respect to the MS/MS data.
The
∏
f models use data that defines some frequency distribution (f ≤1) of
individual modification events then multiples the frequencies together to get
a total score. For instance, phosphorylation of serines are about five times
more common than phosphorylation of threonine (Lee et al., 2006), and
hence guesses that matching this distribution will score higher. This is only
a general outline of the scoring methodology, additional details are provided
in Supplementary Material.
2.4 Implementation
We implemented the PIE in Java 1.5 using ‘best practices’ development
methods including incremental growth and unit testing. To fully evaluate,
one intact mass variant takes about 150 runs of PIE, a total of about
20 min of computer time on a 2010 computer system. Data and scoring are
modularized with each type of data evaluated by a separate scoring module.
This provides flexibility to add new data types in the future through additional
modules. All complex input data are read from simple table-like delimited
text files; output is similarly presented. Rather than complicated command-
line parameters, control information (along with some simple input data)
is provided via a standard java properties file. The program has the ability
to sample multiple times at a given step length. Scripts written in the ‘R’
programming language are included to produce graphical views of the output
similar to the result figures in this article. The program can be download
from http://pie.giddingslab.org/ and a step-by-step tutorial walkthrough is
available (Jefferys and Giddings, 2011).
3 RESULTS
3.1 Analysis of L7/L12 theoretical data
We first tested the PIE program on synthetic data based on a real
protein we had studied in the lab: Escherichia coli ribosomal protein
L7/L12. Manual interpretation of experimental data (Ramkisoon,K.
and Giddings,M.C., unpublished data) suggested the presence of
several isoforms, one of which had three modifications: an N-
terminal methionine loss, an N-terminal acetylation (on 2S) and
a lysine methylation of (82K). Using a theoretical lysC enzyme
digest from PeptideCutter (Gasteiger et al., 2005), we generated
a complete, ideal set of experimental data matching this isoform,
consisting of all bottom-up peptides, complete tandem MS/MS
sequence data, and exact top-down mass. Several datasets with
various levels of error were then produced from this ideal set by
removing peptides and MS/MS sequence, and by adding error into
the intact mass. An estimate for the intact mass accuracy is also
needed, so we choose errors that are near or possibly larger than
the estimated error to show how PIE performs with less than ideal
data. Predictions are summarized in Table 2; complete results are
available as Supplementary Material.
To correctly characterize modification isoforms from typical
proteomic experiments requires obtaining enough data to determine
what modifications are present and where they are located. For this
target isoform, just two peptides (with sequence) serve to identify
the location of the acetyl and methyl adducts, and a moderately
accurate intact mass, within 0.5 Da of the actual value, provides
evidence that the only other modification is a loss of methionine.
At the target’s intact mass of 12 220, 0.5 Da is about 40 ppm. Any
greater intact mass error would support the addition of an amidation
or deamidation modification (±1 Da). The program converged to
the correct answer with a few minutes of runtime for all theoretical
L7/L12 datasets where there was enough data to localize the
modifications (sets 1, 2, 3). By using prior scoring modules, PIE
was able to obtain consistent answers even when either the intact
mass (7 and 8) or the peptide data (4, 5, 6, 9 and 10) did not contain
enough information, i.e. when the intact mass error was large, or
when MS/MS data or peptides are missing. This includes leaving
out all peptide and MS/MS data for one or more modified peptides.
In general, the lack of experimental localization information leads
to multiple equal scoring answers different only in the position of
modifications, but prior scoring modules help to order subsets by
probability, rule out many unlikely answers (i.e. a phosphorylated
arginine), and in some cases obtain the correct localizations (i.e. an
N-terminal acetylation). For the remaining two datasets (11 and 12),
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Table 2. L7/L12 predictions given varying theoretical MS datasets
Theoretical L7/L12 data Imposed intact
error/window (ppm)a
Peptide/MS-MS coverageb Steps Top answer(bold matches expected)c Second answer (bold matches expected)c Score ratio Why?d
1. ideal + 0.5/1 1–14 = 100/100% 50 k 1M-x, 2S-Acet, 82K-Meth 1M-x, 2S-Acet, 76A-Meth 5.72 MS/MS
2. good −23/20 1,3,5,8,12,14 = 50/25% 25 k 1M-x, 2S-Acet, 82K-Meth 1M-x, 2S-Acet, 76A-Meth 5.72 MS/MS
3. min +40/50 1, 8 = 10/10% 25 k 1M-x, 2S-Acet, 82K-Meth 1M-Acet, 2S-Acet, 16S-Acet, 82K-Meth,
86K-Meth, 120V+121K-x
5.33 Intact
4. no tandem +40/50 1, 8 = 10/0% 60 k 1M-x, 2S-Acet, 82K-Meth 1M-x, 2S-Acet, 76A-Meth 1.43 Mod AA
5. no acetyl +40/50 8 = 5/5% 60 k 1M-x, 2S-Acet, 82K-Meth 1M-x, 82K-Meth, K-Meth, K-Meth, K-Meth 1.16 Mod count
6. no methyl +40/50 1 = 5/5% 15 k 1M-x, 2S-Acet, K-Meth 1M-x, 2S-Acet, E-Meth 1.28 Mod AA
7. high intact + 75/100 1, 8 = 10/10% 50 k 1M-x, 2S-Acet, 82K-Meth 1M-x, 2S-Acet, 76A-Meth 1.43 Mod AA
8. low intact −90/100 1, 8 = 10/10% 35 k 1M-x, 2S-Acet, 82K-Meth 1M-x, 2S-Acet, 76A-Meth 1.43 Mod AA
9. no mod −23/20 3, 4, 5, 11, 12, 14 = 50/25% 25 k 1M-x, 2S-Acet, K-Meth 1M-x, 2S-Acet, E-Meth 1.28 Mod AA
10. intact −23/20 0% 250 k 1M-x, 2S-Acet, K-Meth 1M-x, 2S-Acet, 39A-Meth 1.43 Mod AA
11. hi intact +75/100 0% 350 k 1M-x, 2S-Acet, P-Oxid, A-Amid 1M-x, 2S-Acet, K-Meth, 65N-Deam 1.04 Mod type
12. low intact −90/100 0% 50 k 1M-x, 2S-Acet, K-Meth, A-Amid 1M-x, K-Acet, K-Meth, A-Amid 1.91 Rules
aThe actual error in the simulated experimental intact mass and the simulated experimenter’s estimate for the error range.
bModified peptides: 1 has 1M-x (N-terminal methionine loss) + 2S-Acet (n-terminal acetylation), 8 has 82K-Meth (lysine monomethylation). Bold peptides have MS/MS data.
cModifications: #X, amino acid X, at position #; -x, terminal amino acid loss; Acet, acetylation; Met, methylation; Oxid, oxidation; Amid, amidation; Deam, deamidation. Answers
in bold match expected results. Where modifications are given without numbers, multiple equal scoring answers were present with the given modification on the specified AA, but
at different positions.
d‘Why?’ gives the scoring module contributing the most to differentiating the 2 answers (full profiles in Supplementary Material).
the error-adjusted intact mass was off by >40 ppm and no peptide
data were used. Here, the answers obtained by the PIE unsurprisingly
do not match those expected for this target isoform, but instead are
more consistent with the given data and are within 10 ppm of the
intact mass provided.
All datasets were profiled to characterize the quality of the
proposed answer. Full profiles are provided in Supplementary
Material, but the second best answer and the ratio of the top two
answer scores are given in Table 2. Score ratios are consistent with
the ability of PIE to provide greater discrimination between answers
when more data are provided. The highest ratio’s are obtained for
datasets 1, 2 and 3, which are the only ones containing all the
minimum required information for complete characterization of the
isoform. For each of these, the second best answer scores lower due
to its contradiction of experimental data, as indicated in the ‘why’
column of Table 2. This column also shows that, for the remaining
datasets, where not enough experimental information is available,
PIE is using prior expectations to select the best answer, but this is
accompanied by lower score ratios.
3.2 Analysis of H23C theoretical data
As an independent test of the PIE, we developed a synthetic dataset
based on two theoretical isoforms of the human h23c histone protein.
We chose this protein because biologically it is highly modified
and presents a more complex target than L7/L12. Considering
two different isoforms simultaneously allows testing how the PIE
handles conflicting data. One isoform, H5, was generated with two
methylations, two acetylations, one phosphorylation and an N-term
met loss; the other, H7, has two additional phosphorylations (Fig. 2).
From these scenarios, we generated four theoretical datasets: one
set containing peptides, tandem sequence and intact mass consistent
with H5; one set consistent with the additional phosphorylations
present in H7; and the remaining two sets having combined bottom-
up data consistent with a mix of the two isoforms, but using either
the H5 or the H7 intact mass. Predictions are summarized in Table 3;
complete results are available as Supplementary Material.
The program was run assuming each intact mass was in errors
by +10 ppm at ±20 ppm error, and with 3/4 the protein covered by
10K-meth
5K-acet 11S-phos + 15K-acet





Fig. 2. H23C theoretical peptide data. The top white bar shows the
theoretical peptide digest of H23C, blocks aligned below indicate theoretical
peptides provided to the PIE. Those with thick edges indicate MS/MS
sequence data were also provided. Gray boxes indicate unmodified peptides,
other boxes are colored based on the modifications as shown. Some regions of
the protein have no aligned peptide blocks, simulating missing peptides in the
bottom-up data. The second row of peptides are labeled (+H7) to indicate that
in the H7 bottom-up dataset they replace the matching unmodified peptides
from the H5 bottom-up dataset. Both modified and unmodified peptides are
present in the combined bottom-up datasets.
MS/MS peptide data (including all modifications). For the combined
peptide datasets, two regions of the protein have both a correct
and an incorrect peptide assigned to them, the incorrect peptides
originating from a different isoform. The PIE was able to correctly
identify all modifications and their positions for the H5 and H7
pure isoform data and for the H5 mixed case; for the H7 mixed
case it correctly identified all modifications, misplacing just one of
the phosphorylations with conflicting data. For the H5 mixed case,
this means PIE correctly identified and localized all modifications,
and was able to ignore peptide data indicating two additional
phosphorylations that did not apply to H5 isoform. For the H7 mixed
case, this means PIE is reaching the limit of its understanding of the
data. To correctly place this modification, the PIE needs additional
information or modified scoring: see Section 4 for more information.
3.3 Analysis of L7/L12 ribosomal extracts
After validating the PIE on theoretical data (3.1 and 3.2, above), we
applied the PIE to L7/L12 ribosomal extracts collected during an
investigation of the role and extent of ribosomal PTMs in E.coli K-
12 (Ramkisoon,K. and Giddings,M.C., unpublished data). L7/L12 is
particularly complicated and was chosen because there are multiple
isoforms simultaneously present in the sample, testing the PIE’s
ability to handle heterogeneity.
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Peptide setb Steps Top answer (bold matches expected)c Second answer (BOLD matches expected)c Score
ratio
Why?d
H5 −10/20 H5 set 250 k 1M-x, 5K-Acet, 10K-Meth, 11S-Phos, 15K-Acet,
24K-Meth
1M-x, 2A-Acet, 9K-Meth, 10S-Phos, 14K-Acet,
23K-Meth
2.08 Peptide
H7 −10/20 H7 set 375 k 1M-x, 5K-Acet, 10K-Meth, 11S-Phos, [12T-Phos],
15K-Acet, 24K-Meth, [29S-Phos]
1M-x, 5K-Acet, 10K-Meth, 11S-Phos, 12T-Phos,
15K-Acet, 24K-Meth, 32T-Phos
4.35 Peptide
H5both −10/20 H5 plus H7 75 k 1M-x, 5K-Acet, 10K-Meth, 11S-Phos, 15K-Acet,
24K-Meth
1M-x, 2A-Acet, 9K-Meth, 10S-Phos, 14K-Acet,
23K-Meth
2.08 Peptide
H7both −10/20 H5 plus H7 300 k 1M-x, 5K-Acet, 10K-Meth, 11S-Phos, 15K-Acet,
24K-Meth, [29S-Phos], [S-Phos]
5K-Acet, 10K-Meth, 11S-Phos, 15K-Acet, *K-Meth,
*K-Meth, *K-Meth
1.89 Intact
aThe actual error in the simulated experimental intact mass and the simulated experimenter’s estimate for the error range.
bPeptide sets are described in Section 3.
cModifications: #X, amino acid X, at position #; ()X, amino acid X, no unique position; -x, terminal amino acid loss; Acet, acetylation; Met, methylation; Phos, phosphorylation.
Where modifications are given without numbers, multiple equal scoring answers were present with the given modification on the specified AA, but at different positions Answers
in bold match expected results, those in square brackets match modifications present only in the H7.
d‘Why?’ gives the scoring module contributing the most to differentiating the two answers (full profiles in Supplementary Material).
















220-2H 12220.3 50 1M-x, 2S-Acet, 82K-Meth 50 k 1M-x, 2S-Acet, 82K-Meth −17.3 1M-x, K-Acet, 82K-Meth 1.78 Rule
220-1H 12220.1 50 1M-x, 2S-Acet, 82K-Meth 50 k 1M-x, 2S-Acet, 82K-Meth −0.9 1M-x, K-Acet, 82K-Meth 1.78 Rule
207-1L 12206.9 150 1M-x, K-Meth (x2), 82K-Meth 75 k 1M-x, K-Meth (x2), 82K-Meth −65 1M-x, K-Meth, 82K-Meth, 101K-Meth 1.12 Peptide
207-2H 12206.8 50 1M-x, K-Meth (x2), 82K-Meth 75 k 1M-x, K-Meth (x2), 82K-Meth −57 1M-x, K-Meth, 82K-Meth, 101K-Meth 1.12 Peptide
207-1H 12206.5 50 1M-x, K-Meth (x2), 82K-Meth 75 k 1M-x, K-Meth (x2), 82K-Meth −32 1M-x, K-Meth, 82K-Meth, 101K-Meth 1.12 Peptide
206-0H 12206.1 50 1M-x, K-Meth (x2), 82K-Meth 100 k 1M-x, K-Meth (x2), 82K-Meth +0.5 1M-x, K-Meth, 82K-Meth, 101K-Meth 1.12 Peptide
205-0L 12205.5 150 1M-x, K-Meth (x2), 82K-Meth 50 k 1M-x, K-Meth (x2), 82K-Meth +50 1M-x, K-Meth, 82K-Meth, 101K-Meth 1.12 Peptide
175-1M 12174.5 100 1M-x, 82K-Meth 25 k 1M-x, 82K-Meth +292 1M-x, 55F-Amid, 82K-Meth, 115-Myr,
118V-Meth, 120V+121K-x
8.96 Peptide
163-1M 12162.9 100 1M-x 10 k 1M-x, 82K-Meth +1246 1M-x, 2S-x, 81K-Meth, 11E-Acet,
115A-Acet, 116E-Acet
5.56 MS/MA
aManual interpretation taken from investigation of modification isoforms of all ribosomal proteins (Ramkisoon,K. and Giddings,M.C., unpublished data).
bModifications: #X, amino acid X, at position #; -x, terminal amino acid loss; Acet, acetylation; Met, methylation; Myr, myrystolation; Amid, amidation. Where modifications are
given without numbers, multiple equal scoring answers were present with the given modification on the specified AA, but at different positions. Answers in bold match manual
interpretation. For the 205, 206 and 207 isoforms, PIE’s answer caused a partial revision of the potential manual results.
cIntact mass difference gives the difference in theoretical intact mass of the guess relative to the experimental intact mass of the isoform.
d‘Why?’gives the scoring module contributing the most to differentiating the two answers (full profiles in Supplementary Material).
Top-down (intact mass) measurements were collected from
several ribosomal extracts analyzed on two different mass
spectrometers: a Bruker BioTOF II time-of-flight MS and a Fourier
transform ion cyclotron resonance (FTICR) MS. Mass resolution for
the BioTOF typically runs around 20 ppm and for the FTICR around
1 ppm.
A total of nine intact masses were selected from the MS
data as corresponding to isoforms of L7/L12. The intact scoring
model requires some estimate for the accuracy of these masses,
although a precise estimate is not needed. We could simply have
used the expected accuracy for the analyzing instruments, but
the presence of internal standard analogs provides the opportunity
for a second estimate. We calculated the mass error for all other
apparently unmodified ribosomal proteins identified in the extract.
Misidentification of one or more protein as unmodified is possible
as these are not true internal standards, but this only makes our
error estimate more conservative. The intact error windows used in




methyl + methyl with MS/MS
Fig. 3. Escherichia coli L7L12 peptide data. As in Figure 2, the top white
bar shows the theoretical peptide digest, blocks aligned below indicate
theoretical peptides. Those with thick edges indicate that MS/MS sequence
data were provided. Gray boxes indicate unmodified peptides; other boxes
are colored based on the modifications as shown. All peptides were provided
to PIE, peptides are on separate lines only to show the overlapping and
contradictory nature of the data.
Corresponding bottom-up peptide data for L7/L12 were obtained
from E.coli K-12 ribosomal extracts by digestion with trypsin and
analysis on a QSTAR MS/MS Quadrupole time-of-flight. Eighteen
unique peptides were identified by precursor masses including six
with adduct modifications. MS/MS sequence was obtained for six
peptides, including three of those with modifications (Fig. 3).
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Fig. 4. Convergence and profile sampling, L7/L12 220-1H. Each row
represents a different guess proposed by PIE, with guesses in each figure
ordered by score from top (hi) to bottom (lo). The peptide dataset is
reproduced to scale at the bottom of the figure. Colored dots represent
modifications—methyl (blue), acetyl (purple), formyl (green), hydroxyl
(brown) and myristoyl (olive)—each aligned at their proposed positions.
Gray blocks at the left and right indicate N- or C-terminal truncations.
Guesses without horizontal gray lines indicate they have the exact same score
as the guess above, generating blocks of identically scoring guesses. The
jagged black line running roughly diagonally through the graph indicates the
score for each row, like a bar graph, except turned on its side with maximum
value to the right. Scanning the images by sliding a straight edge top to
bottom or left to right provides an ‘animated’ display that helps interpret
modification alignments. (A) 10 samples taken after 50 000 steps. Although
the highest score (guess) has been found twice, this is not clear evidence
for convergence, so a longer length run set is necessary. (B) Ten samples
taken after 250 000 steps. The same highest score (guess) is found here
as was found in the 50 000 step set, and it is found many more times.
This indicates convergence has probably been reached, and this is likely
the best answer given the data. (C) Profile of 100 samples. To look for
alternate interpretations for the data, a profile of guesses is sampled at a
step length providing 20% of the answers as the best scoring candidate, and
80% as other suboptimal guesses. Estimated from the convergence plots,
(A) shows this to be 50 000 steps. By examining these nearby answers it is
possible to see not just how strongly a guess is supported, but how strongly
different features of a guess are supported. The best guess with its specifically
localized acetylation and methylation is approximately twice as good as the
next bess guess (black scoring bar drops to half between them). All high
scoring guesses have a predicted N-terminal methionine loss and an 82K
methylation, indicating no consistent predictions could be made that did
not include these features. Most suboptimal guesses have an acetylation.
In the best scoring guess its localization is on the new N-terminus, 2S.
The PIE was applied to each of the nine intact mass targets,
scoring the combined intact mass and bottom-up experimental data
along with all available prior data models using default parameters.
Figure 4A and B show two of the run sets used to identify
convergence for one of the targets. The PIE converged to a best
prediction for each of the nine targets, describing three different
isoforms. The results summarized in Table 4 were consistent with a
manual interpretation for eight of the nine intact targets (complete
results are available as Supplementary Material). Three separate
isoforms were identified, 12 206, 12 175 and 12 220. These were
each consistent with prior manual analysis, including localization
of one to three modifications and an N-terminal methionine
cleavage. One of the nine intact masses, putatively representing
a fourth isoform at 12 163 Da, was incorrectly predicted to be
mono-methylated; manual interpretation suggests this isoform is
unmodified except for N-terminal methionine loss.
Each of the nine targets was profiled, and the second best guess
along with its relative score ratio are also included in Table 4.
Figure 4C shows the profile for one of the targets, 12 220-H1. For the
tri-methylated prediction, there is not enough data to localize two of
the methyl adduct, so there are many nearby answers differentiated
only by placement of the modifications. When the nearby best
answers have similar scores, the score ratio is near 1, indicating
multiple answers are supported by the data.
4 DISCUSSION
To investigate the feasibility of McMC/SA-based data integration,
we sought answers to questions such as: Could we avoid being
lost in endless sea of equal-mass answers, particularly given
only incomplete data? Can the system handle datasets that have
dependencies, errors or contradictions? Because McMC and SA are
computationally intensive, can we find answers in a reasonable time?
Can we develop the approach into a practical and modular program
that works well now, but can readily accommodate additional data
types in the future?
Data integration in proteomics is difficult because data are usually
incomplete and the solution space is ambiguous, especially when
proteins have multiple modifications. Given the results obtained
above, McMC and SA appear to be a useful way to approach this
problem. Predictions for simply modified proteins are easy to obtain.
For data representing a single protein isoform with only one or two
If not there, the second best scoring guess places it on a lysine aligned with a
missing peptide (see Supplementary Material for specifics). Here, the effect
of the prior data module implementing the AA preference of modifications
can be seen, as lysine is the most commonly acetylated modification, as well
as the effect of the peptide data model, since peptides provide information
that any covered lysine is probably not modified. Unfortunately, no other
information is available to distinguish between these three positions, so
there are three different equally likely predictions made as the second best
guess. Other less likely answers include different positions for the acetyl
modification, a tetra-methyl species, and a dimethyl + formyl species. Two
rare, bad guesses suggest methyl + acetyl + hydroxyl + myristoyl, along with
a cleavage of 1 N-term and 2 C-term amino acids, but even these rare guesses
are in agreement with the intact mass data. They are approximately isobaric
to the best guess, but score much lower due to multiple conflicts with peptide,
MS/MS and prior data modules.
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modifications, interpretation is easy and many methods should work
well. However, the situation becomes rapidly more complex with
just a few isoforms, each with several modifications, especially given
missing or contradictory data and differentially modified peptides. In
these more complex cases, the combinatoric explosion of possible
answers require algorithms—like SA—that scale well. These are
also the cases where we need the most interpretive help. The PIE’s
surprising ability to obtain useful results from intact data alone (as
in Table 2, dataset 10) encouraged us to try bottom-up data with
peptides from several isoforms, relying on the idea that the intact
mass would allow distinguishing the relevant peptides. The PIE did
so well interpreting these complex mixtures—even coming up with
an answer not previously considered during manual analysis—that
we chose to focus this article on these more complicated datasets.
Having multiple interpretations for the same dataset makes
mass spectrometer data difficult to analyze. For example, the data
for the L7/L12 isoform 12 206 supports either tri-methylation or
acetylation. Which is correct? Given the available mass spectrometer
data, it is impossible for human or software to tell. PIE’s tri-methyl
prediction results from the multiple methylated peptides in the
bottom-up data. Which prediction is correct is indeterminate, and
it is our belief that both isoforms may be present. It is interesting
that before using the PIE we had not previously considered tri-
methylation since a manual interpretation of an acetylation was so
‘obvious’. Also, without assuming completeness, there is no reason
to believe all the intact masses have been found, and hence no reason
to believe the di-methylated peptides (Fig. 3) have to belong to any of
the intact masses. The only answer is to acquire more data, but how
and what data? This is essentially a resource availability question,
and depends on the specifics of the experiment and data. If, for
example, ultra-high mass accuracy instrumentation was available
(i.e. an FTICR-MS), it would be possible to resolve the ∼0.03 Da
difference between a tri-methylation and an acetylation.
This lack of specificity in MS data makes it critical for automated
analysis software to integrate a wide range of data. Without the
flexibility to incorporate new techniques, any such software will
quickly become obsolete, whereas software supporting a wide
variety of data allows the experimenter to choose the fastest,
cheapest and most accurate methods to produce data. Modularity
is central to the PIE, allowing simultaneous integration of a variety
of both MS and non-MS-based data. New modules can be added with
relative ease, and it is easy to run ‘what-if’ experiments including
or excluding data.
One important aspect of the way we used bottom-up data was to
specify what not to look for. Modifications not detected in bottom-up
data are, less likely to be present. We use this ‘negative information’
to help the PIE apply Occam’s Razor and favor simpler answers.
For example, without peptide data, the intact data model causes PIE
to add extra amidations or deamidations (±1 Da modifications) to
better match any deviation in intact mass >0.5 Da, even if such
deviation is due to measurement error and not the presence of a
modification (as in Table 2, dataset 12). Where bottom-up data was
available and no such modifications were seen, this chance that such
a modification would be proposed is reduced.
4.1 Model and data accuracy
Scoring is affected both by the accuracy and completeness of
the available data as well as the accuracy of the model itself.
Prior modules are based on information obtained from databases
that suffer from ascertainment bias. The modifications present in
the protein data bank (PDB), for example, are not independently
sampled from all proteins, but are more like an applause meter,
where popular or interesting proteins and their modifications are
overrepresented. We chose simple priors to allow for fast calculation;
given the bias in the underlying data, additional effort to refine them
to provide highly accurate prior models seems unproductive.
The intact mass model is dependent entirely on the accuracy of the
measurement. As shown in the results, if the intact mass has enough
error, PIE will find a consistent answer that is also in error. Although
PIE performed surprisingly well even with wide mass tolerances,
narrower windows increase discriminating power.
The peptide model had difficulty dealing with isoform mixtures
due to data conflicts inherent in a bottom-up shotgun approach. We
tried several models to allow discrimination of multiple isoforms,
but no simple model worked to our satisfaction as the peptide with
the most variants can override other information. Compared with the
consistent tri-methylated proposal obtained for the L7/L12 12,175
isoform, the methylation proposed for the 12 163 variant is not
supported by the intact mass. Here, matching to the intact mass data
by the intact mass model is outweighed by stronger matching to the
peptide data as evaluated by the peptide model. This is due to the
large number of methylated peptides, and might be avoided with an
improved scoring model. Increasing accuracy in intact mass would
also eventually reverse this, producing the expected manual answer.
Additional data on the relative abundance of peptides could help
identify the most prevalent isoform, but would decrease the ability
to identify all others. The underlying McMC and SA algorithms can
optimize continuous values as well as discrete ones, and it is possible
that PIE could be extended to include ‘guesses’ with quantification
estimates for an isoform. However, we have no immediate plans to
do so.
PIE uses a score ratio derived from the answer profile in
lieu of a formal error model (e.g. P-value). The answer profile
samples directly from the empirical distribution, with the ratio
of any two scores giving the ratio of their probabilities. It also
represents how unique a given answer is. As the incomplete and
ambiguous nature of MS data supports multiple similar answers,
it is important to determine if other good answers are likely. It
is not clear how to generate a more meaningful error model.
Bootstrapping can have difficulty with extreme values (Kysely,
2009) and pure McMC sampling (without SA) is computationally
expensive. Additionally, these or similar error models only provide
probabilities or confidence intervals with respect to the model used.
The modular data framework used by PIE is designed to allow
change models easily.
5 CONCLUSION
The current version of the PIE is only the first step in creating
a tool that can integrate MS data and predict PTMs, but already
it shows great promise. Using SA allows the PIE to explore the
unfathomably large solution space of all possible modifications of
a protein, and find the consistent answers. It is surprisingly robust,
capable of decomposing an intact mass into a likely combination of
modifications, and with the addition of MS/MS data, even a complex
mixture of overlapping and conflicting peptides from several
isoforms can be used to obtain specific modifications localizations.
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The PIE provides an integrated approach for combining TDBU MS
data in the context of prior knowledge to automatically determine the
PTMs associated with a protein. By starting with few assumptions
about the answer needed and using a flexible, modular framework
that lets the data provide the constraints, the PIE can be extended and
improved as new or better data and data models become available.
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